Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
74.34
-3.86 (-4.94%)
At close: Jul 31, 2026, 4:00 PM EDT
74.75
+0.41 (0.55%)
After-hours: Jul 31, 2026, 7:34 PM EDT

KNSA Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
243.6214.27202.13180.86156.8137.79122.54112.21108.6379.8683.467.0571.4748.3561.8899.1426.9732.1918.7512.1
Revenue Growth (YoY)
55.36%55.51%64.95%61.17%44.34%72.54%46.93%67.37%51.99%65.18%34.76%-32.37%164.99%50.19%230.14%719.64%250.10%---
Cost of Revenue
23.5720.820.9520.2618.617.8717.920.1112.3210.589.589.097.77.046.716.945.034.223.872.77
Gross Profit
220.03193.47181.18160.6138.19119.92104.6492.1196.3169.2873.8157.9663.7741.3155.1792.221.9427.9714.889.33
Selling, General & Admin
63.8761.1556.7849.146.8643.5340.5446.442.438.6836.7434.4729.1829.0527.2224.6823.8422.2222.7420.76
Research & Development
40.927.4834.6124.1718.7519.3335.2226.0624.0226.3320.0517.1123.7715.1714.3916.4913.820.8227.4319.24
Other Operating Expenses
88.0775.5870.0363.3152.4243.7948.1929.3130.0120.816.9417.3113.998.297.524.623.678.250.84-
Total Operating Expenses
192.83164.2161.41136.58118.03106.65123.94101.7696.4385.8273.7368.8966.9352.5149.1345.7941.3151.2951.0140
Operating Income
27.1929.2719.7724.0220.1613.27-19.3-9.66-0.12-16.540.08-10.93-3.15-11.26.0546.41-19.37-23.32-36.13-30.67
Interest Income
-------------------0.01
Other Non-Operating Income (Expense)
3.953.413.53.142.722.292.322.462.422.272.372.431.921.830.790.320.10.03--
Total Non-Operating Income (Expense)
3.953.413.53.142.722.292.322.462.422.272.372.431.921.830.790.320.10.03-0.01
Pretax Income
31.1532.6823.2727.1622.8815.57-16.98-7.22.3-14.282.45-8.5-1.24-9.366.8446.74-19.27-23.29-36.05-30.66
Provision for Income Taxes
5.7110.09-8.725.057.03-5.496.213.43-22.795.36-16.212.912.38-177.360.721.930.28-0.12
Net Income
25.4322.5914.218.4417.838.54-8.89-12.69-3.91-17.725.24-13.8614.97-12.274.46224.09-19.98-25.21-36.33-30.54
Net Income to Common
25.4322.5914.218.4417.838.54-8.89-12.69-3.91-17.725.24-13.8614.97-12.274.46224.09-19.98-25.21-36.33-30.54
Net Income Growth (YoY)
42.62%164.57%--------465.73%---------
Shares Outstanding (Basic)
7877767573737272717170707070706969696969
Shares Outstanding (Diluted)
8382828078767272717173707270717169696969
Shares Change (YoY)
7.00%8.23%12.79%11.58%9.77%7.80%-0.47%2.20%-0.88%1.26%1.81%-0.52%3.38%0.89%3.48%2.75%1.31%1.27%1.33%4.10%
EPS (Basic)
0.330.30-0.190.250.240.12-0.12-0.18-0.06-0.250.36-0.200.21-0.180.063.23-0.29-0.36-0.53-0.44
EPS (Diluted)
0.300.27-0.190.230.230.11-0.12-0.18-0.06-0.250.35-0.200.21-0.180.063.18-0.29-0.36-0.53-0.44
EPS Growth (YoY)
30.44%145.46%--------483.33%---------
Free Cash Flow
46.5350.0453.2633.0127.9322.2318.58-2.245.173.94.2716.97-3.78-4.29-11.5462.03-7.94-36.85-19.14-28.56
Free Cash Flow Growth (YoY)
66.63%125.14%186.70%-440.34%469.43%335.16%-----72.64%--------
Free Cash Flow Per Share
0.560.610.650.410.360.290.26-0.030.070.060.060.24-0.05-0.06-0.160.88-0.11-0.53-0.28-0.42
Gross Margin
90.32%90.29%89.64%88.80%88.14%87.03%85.40%82.08%88.66%86.75%88.51%86.45%89.23%85.45%89.16%93.00%81.35%86.89%79.37%77.12%
Operating Margin
11.16%13.66%9.78%13.28%12.86%9.63%-15.75%-8.61%-0.11%-20.71%0.10%-16.30%-4.41%-23.16%9.77%46.82%-71.81%-72.44%-192.75%-253.55%
Profit Margin
10.44%10.54%7.02%10.19%11.37%6.20%-7.25%-11.31%-3.60%-22.17%30.26%-20.66%20.95%-25.38%7.21%226.05%-74.08%-78.32%-193.83%-252.53%
FCF Margin
19.10%23.35%26.35%18.25%17.81%16.13%15.16%-1.99%4.76%4.89%5.12%25.31%-5.28%-8.88%-18.65%62.57%-29.43%-114.47%-102.08%-236.13%
EBITDA
27.6729.7420.2424.4120.5213.62-18.9-9.260.31-16.080.62-10.32-2.55-10.66.6546.91-18.72-22.66-35.46-30.01
EBITDA Margin
11.36%13.88%10.01%13.49%13.09%9.88%-15.42%-8.25%0.29%-20.13%0.74%-15.40%-3.57%-21.93%10.74%47.32%-69.39%-70.41%-189.19%-248.11%
EBIT
27.1929.2719.7724.0220.1613.27-19.3-9.66-0.12-16.540.08-10.93-3.15-11.26.0546.41-19.37-23.32-36.13-30.67
EBIT Margin
11.16%13.66%9.78%13.28%12.86%9.63%-15.75%-8.61%-0.11%-20.71%0.10%-16.30%-4.41%-23.16%9.77%46.82%-71.81%-72.44%-192.75%-253.55%
Effective Tax Rate
18.34%30.87%0.00%32.12%22.05%45.14%0.00%-76.27%269.62%-24.01%-930.08%-63.02%1308.39%-31.03%34.79%-379.50%-3.72%-8.27%-0.77%0.38%
SEC Filings: 10-K · 10-Q